美国血液学会2026年铁缺乏诊断指南
美国血液学会(ASH)基于系统证据审查制定2026年铁缺乏诊断指南,采用GRADE方法形成5条推荐。指南聚焦不同人群的血清铁蛋白阈值,强调无论是否贫血均应优先诊断铁缺乏,并给出炎症状态下诊断注意事项及研究空白。
要点
- 推荐针对特定人群采用血清铁蛋白阈值诊断铁缺乏。
- 诊断铁缺乏不应依赖是否合并贫血,应优先识别铁缺乏。
- 炎症状态下诊断铁缺乏需考虑其他阈值或调整策略。
核心结论
- 指南形成5条推荐,核心包括特定人群的血清铁蛋白阈值及炎症状态下铁缺乏诊断指导。
研究设计与样本
- ASH成立多学科指南小组(含1名患者代表),由堪萨斯大学卫生系统支持系统证据审查至2025年7月,采用GRADE方法制定推荐并公开征求意见。
主要发现
- 证据审查覆盖不同人群铁缺乏患病率及诊断阈值相关研究。
- 小组就5条推荐达成共识,并识别文献空白与研究优先方向。
关键数值与推荐
- 推荐包括针对特定人群的血清铁蛋白阈值。
- 推荐无论是否贫血均应优先诊断铁缺乏。
- 推荐包含对其他诊断阈值的考量说明及炎症状态下铁缺乏诊断指导。
临床怎么用
- 临床应依据特定人群的血清铁蛋白阈值诊断铁缺乏,不因无贫血而排除诊断。
- 对存在炎症者,需参考指南中关于其他诊断阈值或调整策略的说明进行判读。
局限性
- 原文未报告具体血清铁蛋白阈值数值、证据质量分级及推荐强度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Iron deficiency is the most common micronutrient deficiency and, when untreated, progresses to anemia. Existing guidance on the diagnostic criteria for iron deficiency is limited and not evidence based. OBJECTIVE: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in their decisions about the diagnosis of iron deficiency, taking a global perspective in all settings. METHODS: ASH established a multidisciplinary guideline panel that included 1 patient representative and was balanced to minimize potential bias from conflicts of interest. The University of Kansas Health System supported the guideline-development process, including performing systematic evidence reviews on the prevalence of iron deficiency across populations and studies to inform diagnostic thresholds up to July 2025. The panel prioritized clinical questions according to clinical impact and high-risk populations. The panel used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach, including GRADE Evidence-to-Decision frameworks, to assess evidence and make recommendations, which were subsequently open for public comment. RESULTS: The panel agreed on 5 recommendations. CONCLUSIONS: Key recommendations of these guidelines include serum ferritin thresholds for specific populations, with the goal to prioritize the diagnosis of iron deficiency, irrespective of the presence of anemia, remarks for considerations of other diagnostic thresholds, and guidance on the diagnosis of iron deficiency in persons with inflammation. Gaps in the literature and research priorities were also identified.
引用
- Powers JM, Lim MY, Achebe MO, et al. American Society of Hematology 2026 guidelines for diagnosis of iron deficiency. Blood Adv. 2026. PMID: 42747316. doi:10.1182/bloodadvances.2025015950
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。